1061 related articles for article (PubMed ID: 15788499)
1. Polycystic ovary syndrome.
Ehrmann DA
N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
[No Abstract] [Full Text] [Related]
2. Syndromes of hyperandrogenism in women.
Davis S
Aust Fam Physician; 1999 May; 28(5):447-51. PubMed ID: 10376368
[TBL] [Abstract][Full Text] [Related]
3. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment of polycystic ovary syndrome.
Ehrmann DA; Rychlik D
Semin Reprod Med; 2003 Aug; 21(3):277-83. PubMed ID: 14593550
[TBL] [Abstract][Full Text] [Related]
5. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
Kuscu NK; Koyuncu FM
Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
[TBL] [Abstract][Full Text] [Related]
6. Insulin-sensitizing agents in polycystic ovary syndrome.
Pasquali R; Gambineri A
Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of polycystic ovary syndrome].
Langmár Z
Orv Hetil; 2010 Apr; 151(14):584-6. PubMed ID: 20332077
[No Abstract] [Full Text] [Related]
8. Polycystic ovary syndrome in adolescents.
Kent SC; Legro RS
Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
[TBL] [Abstract][Full Text] [Related]
9. [Insulin sensitizers in the treatment of polycystic ovary].
Ortiz Núñez DA; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
[TBL] [Abstract][Full Text] [Related]
10. New adolescent polycystic ovary syndrome perspectives.
Alemzadeh R; Kansra AR
Minerva Pediatr; 2011 Feb; 63(1):35-47. PubMed ID: 21311428
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones for treatment of polycystic ovary syndrome.
Stout DL; Fugate SE
Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.
Kulshreshtha B; Gupta N; Ganie MA; Ammini AC
Gynecol Endocrinol; 2012 Oct; 28(10):823-6. PubMed ID: 22475072
[TBL] [Abstract][Full Text] [Related]
13. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Sharma ST; Nestler JE
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitizing agents in women with polycystic ovary syndrome.
Pasquali R; Gambineri A
Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
[TBL] [Abstract][Full Text] [Related]
15. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Harborne L; Fleming R; Lyall H; Sattar N; Norman J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273
[TBL] [Abstract][Full Text] [Related]
16. Insulin-sensitising agents in polycystic-ovary syndrome.
Sattar N; Hopkinson ZE; Greer IA
Lancet; 1998 Jan; 351(9099):305-7. PubMed ID: 9652605
[No Abstract] [Full Text] [Related]
17. [Polycystic ovary syndrome. Diet helps control hormone chaos].
Klein F
MMW Fortschr Med; 2009 Sep; 151(37):16. PubMed ID: 19827418
[No Abstract] [Full Text] [Related]
18. Diagnosis and treatment of polycystic ovarian syndrome.
Jones AE
Nurs Times; 2005 Jan 18-24; 101(3):40-3. PubMed ID: 15693578
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk in women with polycystic ovary syndrome.
Cho LW; Atkin SL
Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
